Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zejun Yang

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Electrophysiology|September 3, 2025
Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic SyndromeYang Xu, Zixu Zhao, Hui Xu, et al.
Heart Rhythm|August 16, 2025
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with chronic kidney diseaseHui Xu, Zixu Zhao, Yang Xu, et al.
International Journal of Surgery (London, England)|August 7, 2025
Benefits of first-pass reperfusion - secondary analysis based on three randomized multicenter trials in ChinaJie Cao, Zejun Yang, Yidan Zhu, et al.
Heart Rhythm|April 18, 2025
Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trialTing Shen, Mingxiao Li, Manlin Zhao, et al.
Heart Rhythm|June 20, 2024
Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablationZejun Yang, Jue Wang, Chao Jiang, et al.
Journal of the American Heart Association|April 18, 2025
Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial FibrillationSitong Li, Jingrui Zhang, Song Zuo, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2023
Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT TrialJue Wang, Chao Jiang, Sitong Li, et al.
Heart Rhythm|May 26, 2026
Single Antiplatelet Therapy vs Oral Anticoagulation Monotherapy in Patients With Atrial Fibrillation and Coronary Artery Disease After Successful Catheter Ablation: A Target Trial EmulationFadong Li, Yize Zhao, Xiaodong Peng, et al.
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Burden of Atrial Fibrillation and Atrial Flutter From 1990 to 2021 in China: Global Burden of Disease Study 2021 UpdateXiangyi Kong, Mingxiao Li, Liu He, et al.
Heart Rhythm|August 21, 2024
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failureZixu Zhao, Yiping Wang, Chao Jiang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Electrophysiology|September 3, 2025
Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic SyndromeYang Xu, Zixu Zhao, Hui Xu, et al.
Heart Rhythm|August 16, 2025
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with chronic kidney diseaseHui Xu, Zixu Zhao, Yang Xu, et al.
International Journal of Surgery (London, England)|August 7, 2025
Benefits of first-pass reperfusion - secondary analysis based on three randomized multicenter trials in ChinaJie Cao, Zejun Yang, Yidan Zhu, et al.
Heart Rhythm|April 18, 2025
Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trialTing Shen, Mingxiao Li, Manlin Zhao, et al.
Heart Rhythm|June 20, 2024
Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablationZejun Yang, Jue Wang, Chao Jiang, et al.
Journal of the American Heart Association|April 18, 2025
Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial FibrillationSitong Li, Jingrui Zhang, Song Zuo, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2023
Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT TrialJue Wang, Chao Jiang, Sitong Li, et al.
Heart Rhythm|May 26, 2026
Single Antiplatelet Therapy vs Oral Anticoagulation Monotherapy in Patients With Atrial Fibrillation and Coronary Artery Disease After Successful Catheter Ablation: A Target Trial EmulationFadong Li, Yize Zhao, Xiaodong Peng, et al.
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Burden of Atrial Fibrillation and Atrial Flutter From 1990 to 2021 in China: Global Burden of Disease Study 2021 UpdateXiangyi Kong, Mingxiao Li, Liu He, et al.
Heart Rhythm|August 21, 2024
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failureZixu Zhao, Yiping Wang, Chao Jiang, et al.
Pageof 4